News

AddToAny

Google+ Facebook Twitter Twitter

COVID-19: "Nanofibre swabs more sensitive"

Ultra-absorptive nanofibre swabs could reduce the number of false-negative tests by improving sample collection and test sensitivity, it is claimed.

Currently, the most sensitive test for COVID-19 involves using a long swab to collect a specimen from deep inside a patient’s nose, then RT-PCR to detect SARS-CoV-2 RNA. 

But if the viral load is low, the swab might not pick up enough virus to be detectable. 

A team of researchers wanted to develop a nanofibre swab that could absorb and then release more viruses and other biological specimens, improving the sensitivity of diagnostic tests.

They used an electrospinning technique to make 1cm-long cylinders composed of aligned nanofibre layers, which they coated with a thin layer of gelatin and bonded to plastic swab sticks. 

In lab tests, the porous nanofibre cylinders absorbed and released more proteins, cells, bacteria, DNA and viruses from liquids and surfaces than the cotton or flocked swabs commonly used for COVID-19 testing. 

The team made dilutions of SARS-CoV-2 virus, swabbed the liquid samples and tested for viral RNA with RT-PCR. 

Compared with the two other types of swabs, the nanofibre ones reduced the false-negative rate and detected SARS-CoV-2 at a 10-times lower concentration. 

In addition to allowing more accurate and sensitive COVID-19 testing, the nanofibre swabs have far-reaching potential in diagnosing other diseases, testing for foodborne illnesses and helping forensic teams identify crime suspects from miniscule biological specimens, the researchers say.

bit.ly/2O4qp2j

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top